Not only have those dealing withchronic conditions become addicted to painkillers due to what werelikely inappropriate prescriptions, but prescriptions often includefar more pills than necessary. (Photo: Shutterstock)

|

The FDA has come under bipartisan fire in recent years for itsoversight of opioids. Treatment advocates and lawmakers have blamedthe agency for turning a blind eye to the widespread abuse of prescription medication,both by approving powerful new opioids for medical use and forfailing to put in place effective rules to prevent inappropriateprescriptions.

|

The agency has proposed new rules that will require drugmakersto conduct studies examining the effectiveness of their medicationswhen used for chronic conditions.

|

The rules aim to address the fact that doctors are oftenprescribing highly addictive drugs to treat chronic pain. Manyexperts have argued that powerful opioids should only be usedoccasionally to treat acute pain.

|

Related: Employers ignorant of employee opioiduse

|

Notably, the FDA approved the use of OxyContin for chronic painwith no evidence that it can effectively reduce pain in thelong-term.

|

“There are certain important questions that we could answer byproperly studying the chronic administration, looking at theefficacy over time,” explained FDA Commissioner Scott Gottlieb inrecent testimony to a Congressional committee.

|

Experts have highlighted a number of medical practices that havefacilitated widespread opioid addiction. Not only have thosedealing with chronic conditions become addicted to painkillers dueto what were likely inappropriate prescriptions, but prescriptionsoften include far more pills than necessary to deal with the painthat is being targeted, such as recovering from wisdom toothremoval.

|

Painkiller addiction has played a major role in fueling anexplosion in heroin use, as opioid addicts who have exhausted theirprescriptions turn to a cheaper fix on the street. Since 2017nearly 50,000 Americans have died of opioid overdoses.

|

Read more: 

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.